Insufficient scRNA-seq data for expression of PAGR1 at single-cell level.
Insufficient scRNA-seq data for expression of PAGR1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 3733.67 | 21 / 21 | 100% | 8.06 | 503 / 504 |
prostate | 100% | 5255.55 | 245 / 245 | 100% | 12.05 | 501 / 502 |
uterus | 100% | 7785.54 | 170 / 170 | 99% | 8.02 | 456 / 459 |
brain | 99% | 4847.53 | 2621 / 2642 | 100% | 8.24 | 705 / 705 |
thymus | 100% | 2330.97 | 651 / 653 | 100% | 8.53 | 602 / 605 |
breast | 100% | 1777.48 | 457 / 459 | 100% | 12.65 | 1113 / 1118 |
esophagus | 100% | 2639.63 | 1444 / 1445 | 99% | 5.07 | 181 / 183 |
adrenal gland | 100% | 1913.28 | 258 / 258 | 99% | 9.05 | 227 / 230 |
intestine | 100% | 2865.73 | 965 / 966 | 98% | 7.48 | 518 / 527 |
skin | 99% | 1288.52 | 1786 / 1809 | 99% | 6.62 | 466 / 472 |
lung | 99% | 1708.73 | 571 / 578 | 98% | 6.11 | 1137 / 1155 |
kidney | 99% | 1630.25 | 88 / 89 | 98% | 5.74 | 884 / 901 |
stomach | 99% | 1538.97 | 356 / 359 | 97% | 6.53 | 278 / 286 |
pancreas | 96% | 1006.64 | 314 / 328 | 99% | 6.59 | 177 / 178 |
ovary | 100% | 11329.41 | 180 / 180 | 95% | 4.45 | 407 / 430 |
liver | 96% | 1009.62 | 218 / 226 | 97% | 4.92 | 393 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 7.50 | 29 / 29 |
spleen | 100% | 1629.17 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 7.00 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.91 | 1 / 1 |
blood vessel | 100% | 3469.39 | 1333 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 6.27 | 79 / 80 |
adipose | 99% | 1715.05 | 1187 / 1204 | 0% | 0 | 0 / 0 |
heart | 97% | 1355.09 | 832 / 861 | 0% | 0 | 0 / 0 |
muscle | 91% | 952.81 | 734 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 74% | 1057.26 | 685 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006310 | Biological process | DNA recombination |
GO_0006281 | Biological process | DNA repair |
GO_1902808 | Biological process | positive regulation of cell cycle G1/S phase transition |
GO_0033148 | Biological process | positive regulation of intracellular estrogen receptor signaling pathway |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0035097 | Cellular component | histone methyltransferase complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0044666 | Cellular component | MLL3/4 complex |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0030331 | Molecular function | nuclear estrogen receptor binding |
Gene name | PAGR1 |
Protein name | PAXIP1-associated glutamate-rich protein 1 (Glutamate-rich coactivator interacting with SRC1) (GAS) (PAXIP1-associated protein 1) (PTIP-associated protein 1) |
Synonyms | PA1 C16orf53 |
Description | FUNCTION: Its association with the histone methyltransferase MLL2/MLL3 complex is suggesting a role in epigenetic transcriptional activation. However, in association with PAXIP1/PTIP is proposed to function at least in part independently of the MLL2/MLL3 complex. Proposed to be recruited by PAXIP1 to sites of DNA damage where the PAGR1:PAXIP1 complex is required for cell survival in response to DNA damage independently of the MLL2/MLL3 complex . However, its function in DNA damage has been questioned (By similarity). During immunoglobulin class switching in activated B-cells is involved in transcription regulation of downstream switch regions at the immunoglobulin heavy-chain (Igh) locus independently of the MLL2/MLL3 complex (By similarity). Involved in both estrogen receptor-regulated gene transcription and estrogen-stimulated G1/S cell-cycle transition . Acts as a transcriptional cofactor for nuclear hormone receptors. Inhibits the induction properties of several steroid receptors such as NR3C1, AR and PPARG; the mechanism of inhibition appears to be gene-dependent . . |
Accessions | Q9BTK6 ENST00000320330.8 |